ANCA-associated Vasculitis - 103 Studies Found
| Active, not recruiting |
: Rituximab Vasculitis Maintenance Study :
|
| Completed |
: Low-dose Glucocorticoid Vasculitis Induction Study :
|
| Completed |
: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis : Vasculitis : 2005-08-09 : Drug: azathioprine azathioprine 2 mg/kg oral once daily, duration according to arm |
| Completed |
: Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis :
: Drug: Rituximab |
| Completed |
: Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing : Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis : 2016-03-01 : Drug: Rituximab re-dosing dependent on interventional arm parameter. |
| Completed |
: Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation : Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis : 2014-07-01 : Other: Follow-up Follow-up of of patients with borderline positive ANCA test results |
| Completed |
: Efficacy Study of Two Treatments in the Remission of Vasculitis :
: 2008-09-05 :
|
| Completed |
: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis :
|
| Not yet recruiting |
: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis :
|
| Completed |
: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) :
: |